Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick G Hoggard

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Infectious Diseases|April 20, 2002
Intracellular pharmacology of nucleoside analogues and protease inhibitors: role of transporter moleculesPatrick G Hoggard, David J Back
The Journal of Antimicrobial Chemotherapy|September 6, 2005
Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individualsLisa M Almond, Patrick G Hoggard, Damitha Edirisinghe, et al.
Therapeutic Drug Monitoring|September 28, 2002
Simultaneous determination of rifampicin and efavirenz in plasmaMarta Boffito, John Tija, Helen E Reynolds, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Development of enzymatic assays for quantification of intracellular lamivudine and carbovir triphosphate levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected patientsStephen Kewn, Patrick G Hoggard, Sean D Sales, et al.
Antiviral Therapy|December 3, 2003
Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytesOmar Janneh, Patrick G Hoggard, John F Tjia, et al.
British Journal of Clinical Pharmacology|September 19, 2002
The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjectsMarta Boffito, Patrick G Hoggard, Helen E Reynolds, et al.
Therapeutic Drug Monitoring|January 30, 2004
Lopinavir protein binding in vivo through the 12-hour dosing intervalMarta Boffito, Patrick G Hoggard, W Edward Lindup, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Enzymatic assay for measurement of intracellular DXG triphosphate concentrations in peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected patientsStephen Kewn, Laurene H Wang, Patrick G Hoggard, et al.
The Journal of Antimicrobial Chemotherapy|December 4, 2002
Pharmacokinetics of saquinavir co-administered with cimetidineMarta Boffito, Pierluigi Carriero, Laura Trentini, et al.
AIDS (London, England)|October 9, 2002
Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamicsMarta Boffito, Isabella Arnaudo, Riccardo Raiteri, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Infectious Diseases|April 20, 2002
Intracellular pharmacology of nucleoside analogues and protease inhibitors: role of transporter moleculesPatrick G Hoggard, David J Back
The Journal of Antimicrobial Chemotherapy|September 6, 2005
Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individualsLisa M Almond, Patrick G Hoggard, Damitha Edirisinghe, et al.
Therapeutic Drug Monitoring|September 28, 2002
Simultaneous determination of rifampicin and efavirenz in plasmaMarta Boffito, John Tija, Helen E Reynolds, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Development of enzymatic assays for quantification of intracellular lamivudine and carbovir triphosphate levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected patientsStephen Kewn, Patrick G Hoggard, Sean D Sales, et al.
Antiviral Therapy|December 3, 2003
Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytesOmar Janneh, Patrick G Hoggard, John F Tjia, et al.
British Journal of Clinical Pharmacology|September 19, 2002
The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjectsMarta Boffito, Patrick G Hoggard, Helen E Reynolds, et al.
Therapeutic Drug Monitoring|January 30, 2004
Lopinavir protein binding in vivo through the 12-hour dosing intervalMarta Boffito, Patrick G Hoggard, W Edward Lindup, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Enzymatic assay for measurement of intracellular DXG triphosphate concentrations in peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected patientsStephen Kewn, Laurene H Wang, Patrick G Hoggard, et al.
The Journal of Antimicrobial Chemotherapy|December 4, 2002
Pharmacokinetics of saquinavir co-administered with cimetidineMarta Boffito, Pierluigi Carriero, Laura Trentini, et al.
AIDS (London, England)|October 9, 2002
Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamicsMarta Boffito, Isabella Arnaudo, Riccardo Raiteri, et al.
Pageof 2